No definition available.
Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)
C3_VAGINA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
106 |
4. Check minimum number of eventsNone |
106 |
5. Include endpointsNone |
106 |
6. Filter based on genotype QC (FinnGen only) |
106 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 106 | 106 | - |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | - |
| Median age at first event (years) | 63.13 | 63.13 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 50
- Matched controls
- 499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
35.7
30
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
34.3
29
*
LEB00
NOMESCO Finland
Biopsy of vagina
329.7
31.7
29
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
31.6
27
*
A03FA01
ATC
metoclopramide; systemic, rectal
20.2
18.8
32
40
H02AB02
ATC
dexamethasone; systemic
74.0
17.5
19
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
16.5
15
*
C52.90
ICD-10 Finland
Malignant neoplasm of vagina without histologic examination
+∞
15.4
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.4
14
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
14.2
13
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.2
13
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
14.2
13
*
ULA02
NOMESCO Finland
Kolposcopy
15.3
13.2
23
26
C52
ICD-10 Finland
Malignant neoplasm of vagina
+∞
13.1
12
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
153.8
12.0
12
*
C52.99
ICD-10 Finland
Malignant tumor of the vagina, unspecified histology
+∞
11.9
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.9
11
*
JN4BD
NOMESCO Finland
Extensive body CT
17.2
11.8
19
17
UKC02
NOMESCO Finland
Cystoscopy
12.5
11.1
21
27
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.8
10
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
10.8
10
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
10.8
10
*
A04AA01
ATC
ondansetron; systemic, rectal
23.0
10.7
15
9
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
7.8
10.5
34
106
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
34.1
10.4
13
5
XX3DW
NOMESCO Finland
Time consuming IT work
20.7
10.3
15
10
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.7
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.7
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.7
9
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
8.7
9.3
22
41
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
34.3
8.9
11
*
JN4AD
NOMESCO Finland
Body CT examination
34.3
8.9
11
*
A04AD12
ATC
aprepitant; systemic
+∞
8.6
8
*
LEC00
NOMESCO Finland
Partial excision of vagina
+∞
8.6
8
*
WW500
NOMESCO Finland
Blood transfusion
40.6
8.4
10
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
15.4
8.1
13
11
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.7
8.0
18
30
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.5
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
7.5
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.5
7
*
C52.92
ICD-10 Finland
Adenocarcinoma of the vagina
+∞
7.5
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.5
7
*
N02AA05
ATC
oxycodone; systemic
8.0
7.3
17
30
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.3
7.1
28
97
LEB10
NOMESCO Finland
Excision of lesion of vagina
46.4
7.0
8
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
31.0
6.4
8
*
F43.29
ICD-10 Finland
Adaptation disorder UNS
31.0
6.4
8
*
X77
ICPC
Malignant neopl genital female other
+∞
6.4
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.4
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.4
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.4
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.4
6
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
24
18
16.94
26.27
1.6
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
44
6.40
12.17
3.9
1.4
ug/l
5.0
3.0
0.66
16
34
(40761535) Cells panel - Urine sediment
25
70
4.37
8.46
4.2
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
45
195
3.27
7.96
17.3
4.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
63
336
3.16
7.75
12.0
6.9
inr
1.4
1.2
0.36
14
91
(3023368) Bacteria identified in Blood by Culture
45
201
3.15
7.49
6.8
3.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
35
5.21
7.20
1.6
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
66
373
3.04
7.13
6.8
3.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
195
3.03
6.87
2.3
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
304
2.89
6.74
4.9
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
57
311
2.80
6.36
3.8
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
22
71
3.65
6.03
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
43
228
2.49
4.78
4.2
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
26
107
2.89
4.76
3.3
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
21
5.15
4.63
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
116
2.78
4.56
10.8
7.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
42
231
2.36
4.22
4.3
3.1
e6/l
0.5
0.6
0.35
36
164
(3000991) Gas panel - Venous blood
16
53
3.38
4.17
9.9
5.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
171
2.46
4.16
4.7
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
55
345
2.24
4.00
6.3
3.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
24
4.50
3.98
1.2
1.2
pmol/l
116.4
70.8
—
10
24
(3044640) Blood type and Crossmatch panel - Blood
40
223
2.27
3.84
5.4
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
41
233
2.24
3.75
6.4
4.2
estimate
0.0
0.0
—
10
74
(3002582) Erythrocytes [#/volume] in Urine
43
250
2.21
3.71
4.3
3.3
e6/l
34.0
15.4
0.67
37
182
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
26
121
2.52
3.71
2.5
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
9
8.23
3.61
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
228
2.21
3.61
5.2
3.6
—
—
—
0
0
(3015736) pH of Urine
57
374
2.13
3.59
4.6
3.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
13
6.55
3.57
1.9
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
48
303
2.07
3.27
4.8
4.3
e6/l
156.4
125.7
0.15
37
202
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
11
6.72
3.24
1.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
88
2.57
3.17
2.4
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
12
6.16
3.07
1.6
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
66
475
2.03
3.07
6.4
5.5
estimate
0.0
0.0
—
8
70
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
90
2.51
3.03
2.3
1.8
—
—
—
0
0
(44790048)
5
5
10.40
3.01
1.8
1.0
—
—
—
0
0
(44790047)
5
5
10.40
3.01
1.8
1.0
—
—
—
0
0
(44790049)
5
5
10.40
3.01
1.8
1.0
—
—
—
0
0
(44806118)
5
5
10.40
3.01
1.8
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
17
5.00
2.98
2.1
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
59
2.80
2.93
2.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
66
480
1.99
2.92
5.5
3.9
estimate
0.0
0.0
0.00
11
72
(3019198) Lymphocytes [#/volume] in Blood
61
434
1.96
2.85
9.0
4.9
e9/l
1.4
1.9
4.04
54
375
(3019150) Specific gravity of Urine by Refractometry
37
223
2.01
2.78
5.4
4.1
kg/l
1.0
1.0
—
5
35
(3017181) Myelocytes/100 leukocytes in Blood
14
55
2.78
2.74
3.6
4.8
%
1.3
0.5
—
6
9
(3019060) Gas panel - Arterial blood
13
49
2.88
2.74
6.5
4.9
—
—
—
0
0
(3012544) pH of Venous blood
19
88
2.41
2.71
9.1
3.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
62
449
1.92
2.70
9.5
4.9
e9/l
0.2
0.2
0.33
56
390
(3021447) Carbon dioxide [Partial pressure] in Venous blood
18
83
2.41
2.59
9.4
3.0
kpa
5.2
5.8
2.11
18
83
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
7
7.42
2.57
2.4
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
80
642
2.00
2.44
6.8
4.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
8
6.49
2.40
1.8
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
13
53
2.66
2.38
3.8
5.0
%
0.0
0.1
—
5
9
(3035350) Ketones [Presence] in Urine by Test strip
63
471
1.83
2.36
5.5
3.9
estimate
0.0
0.0
0.00
11
75
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
61
452
1.82
2.35
9.0
4.9
mmol/l
1.2
1.2
2.20
54
401
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
20
101
2.21
2.34
4.4
2.5
%
21.3
22.9
0.16
13
90
(3025159) Blasts/100 leukocytes in Blood
13
54
2.60
2.30
3.8
4.8
%
0.0
10.9
—
5
8
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
18
4.09
2.29
2.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
83
934
0.49
2.20
5.1
5.4
mmol/l
2.9
2.8
0.50
78
861
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
14
4.47
2.18
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
58
432
1.76
2.12
9.3
4.8
e9/l
0.0
0.0
0.49
53
370
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
16
77
2.27
2.09
1.8
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
10
5.18
2.09
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
77
884
0.53
2.08
6.4
5.9
mmol/mol
40.6
39.9
0.26
70
818
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
82
923
0.51
2.05
5.4
4.8
mmol/l
6.0
6.0
0.27
76
841
(3052851) Hemolysis interference index of Serum or Plasma
7
21
3.49
2.00
2.7
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
57
428
1.72
1.99
9.4
4.8
e9/l
0.5
0.6
0.61
52
366
(3007853) Bacteria identified in Skin by Aerobe culture
17
86
2.16
1.98
2.1
1.5
—
—
—
0
0
(3020891) Body temperature
8
27
3.12
1.98
10.1
5.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
30
188
1.83
1.94
1.7
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
17
87
2.14
1.93
10.5
3.4
mmol/l
1.0
1.0
0.15
17
73
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
23
3.18
1.83
1.6
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
41
2.59
1.81
1.8
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
13
62
2.25
1.74
1.8
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
25
2.92
1.68
1.6
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
63
2.21
1.68
1.8
1.7
ml/min/173m2
44.0
57.9
—
5
23
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
155
1.80
1.66
4.2
2.6
e6/l
1.1
1.2
0.07
14
83
(42870588) Differential panel, method unspecified - Blood
39
277
1.65
1.60
10.9
4.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
360
1.61
1.58
3.8
3.8
ng/l
83.7
23.2
0.46
37
254
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
51
2.29
1.56
4.9
2.1
mmol/l
24.5
25.4
0.62
11
51
(3014007) Fractional oxyhemoglobin in Arterial blood
9
39
2.43
1.47
6.1
6.3
%
94.8
94.4
—
9
39
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
16
3.23
1.45
1.4
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
32
222
1.63
1.42
2.6
2.0
mg/l
3.0
3.6
0.68
27
183
(3022145) Colonoscopy Study observation
15
83
1.94
1.40
1.6
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
9
42
2.25
1.37
6.1
5.9
%
0.7
0.7
—
9
42
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
9
42
2.25
1.37
6.1
5.9
%
1.5
1.5
—
9
42
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
17
3.03
1.37
1.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
17
3.03
1.37
1.8
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
361
1.54
1.35
6.2
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
35
2.39
1.30
1.9
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
94
997
0.49
1.28
46.0
17.8
fl
91.8
91.0
0.70
94
976
(3035941) MCH [Entitic mass]
94
997
0.49
1.28
46.0
17.8
pg
30.3
30.1
0.32
94
976
(3000963) Hemoglobin [Mass/volume] in Blood
94
997
0.49
1.28
46.3
18.0
g/l
122.7
132.4
7.95
94
974
(3020630) Protein [Mass/volume] in Serum or Plasma
13
72
1.92
1.21
4.0
1.2
g/l
65.9
67.4
0.22
13
66
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
33
0.00
1.18
0.0
1.9
—
—
—
0
0
(1002224) Polysomnography panel
0
36
0.00
1.16
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
20
291
0.61
1.13
3.9
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
36
270
1.50
1.12
5.7
3.2
ph
7.4
7.4
—
5
36
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
157
0.53
1.09
1.0
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
65
741
0.68
1.06
40.7
14.6
%
14.5
13.7
2.98
65
727
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
48
1.95
1.03
2.3
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
9
49
1.91
1.01
3.1
3.7
—
7.4
—
0
7
(3008898) HLA-B27 [Presence]
0
29
0.00
0.99
0.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
28
0.00
0.99
0.0
1.1
—
397.3
—
0
23
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
9
51
1.83
0.97
3.1
3.5
kpa
4.8
5.3
—
9
45
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
21
145
1.56
0.94
4.5
2.9
e6/l
0.6
4.3
—
10
75
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
12
187
0.60
0.89
1.2
1.3
iu/ml
26.6
43.0
—
5
70
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
30
2.06
0.88
2.0
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
46
1.80
0.84
5.4
2.2
%
0.6
0.6
—
8
46
(3025941) Bacteria identified in Stool by Culture
10
58
1.80
0.83
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
47
1.76
0.83
5.4
2.1
%
1.1
1.2
—
8
47
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
12
183
0.61
0.81
1.2
1.3
u/ml
3.3
10.6
—
7
63
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.80
0.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
25
0.00
0.80
0.0
1.2
—
49.1
—
0
19
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
25
0.00
0.80
0.0
1.0
—
2.9
—
0
19
(3022313) Gas panel - Capillary blood
6
34
1.81
0.77
4.2
3.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
16
109
1.55
0.76
1.5
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
84
1.62
0.76
2.3
3.7
ng/l
449.2
175.8
0.44
13
77
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
40
1.80
0.73
7.4
5.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
79
1.59
0.66
2.9
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
29
1.76
0.64
2.8
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
29
1.76
0.64
1.2
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
29
1.76
0.64
2.0
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
63
1.65
0.64
8.8
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
26
204
1.36
0.62
1.7
1.8
mg/l
1.3
1.0
0.31
20
162
(3044290) Cell count panel - Cerebral spinal fluid
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
23
179
1.36
0.58
7.7
4.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
66
1.57
0.55
3.6
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
39
1.57
0.54
1.8
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
40
1.53
0.52
2.3
2.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
47
1.52
0.48
6.1
2.5
%
51.9
44.0
—
7
47
(40768797) Stomach Pathology biopsy report
10
140
0.68
0.47
1.7
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
36
308
1.26
0.46
2.6
2.9
mmol/l
6.2
6.3
0.06
29
254
(3013707) Erythrocyte sedimentation rate by Westergren method
63
684
0.81
0.46
3.5
4.5
mm/h
16.2
12.9
0.85
57
627
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
21.7
—
0
15
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
17
0.00
0.41
0.0
2.0
—
15.8
—
0
9
(3041354) Potassium [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
1.9
—
4.0
—
0
19
(3013290) Carbon dioxide [Partial pressure] in Blood
0
19
0.00
0.39
0.0
2.5
—
5.2
—
0
19
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
19
0.00
0.39
0.0
2.5
—
8.1
—
0
19
(3035285) Chloride [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
1.9
—
104.5
—
0
19
(3012501) Base excess in Blood by calculation
0
19
0.00
0.39
0.0
2.5
—
2.8
—
0
13
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
36
1.41
0.38
1.0
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
76
0.64
0.37
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
94
969
0.74
0.35
18.5
8.9
u/l
23.0
22.7
0.09
94
925
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
45
1.35
0.34
1.2
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
76
800
0.82
0.34
32.3
13.5
%
37.0
39.5
2.70
51
554
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
47
512
0.85
0.30
2.8
2.8
—
—
—
0
0
(3013512) EKG study
32
284
1.18
0.28
3.6
3.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
93
902
1.25
0.26
28.3
12.0
mg/l
29.7
20.0
2.17
85
658
(4010399)
9
76
1.20
0.25
1.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
97
1.27
0.24
1.2
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
37
1.37
0.24
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
37
1.37
0.24
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
38
1.33
0.23
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
41
1.23
0.22
1.2
1.6
—
—
—
0
0
(3019225) pH of Specimen
11
89
1.26
0.22
4.1
3.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
11
0.00
0.21
0.0
1.6
—
91.5
—
0
11
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4268621)
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
4.0
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
19
215
0.86
0.19
1.2
1.3
u/ml
0.8
2.7
—
8
51
(3004588) Protein electrophoresis panel - Serum or Plasma
5
66
0.75
0.17
1.0
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
93
949
0.84
0.16
31.4
14.5
mmol/l
138.8
139.9
2.68
93
920
(3023103) Potassium [Moles/volume] in Serum or Plasma
93
949
0.84
0.16
31.4
14.6
mmol/l
4.0
4.0
0.19
93
919
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
39
414
0.91
0.14
1.9
2.1
pmol/l
94.2
103.1
0.32
19
183
(3021589) Normoblasts [#/volume] in Blood
39
371
1.08
0.10
19.5
7.6
e9/l
0.0
0.0
0.72
34
306
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
48
1.04
0.09
1.6
1.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
20.8
4.0
mmol/l
26.0
25.4
—
5
48
(21494755) Public health laboratory ask at order entry panel
6
53
1.14
0.09
1.2
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
94
953
0.88
0.09
33.0
14.0
umol/l
79.2
70.5
0.73
94
953
(3001122) Ferritin [Mass/volume] in Serum or Plasma
40
383
1.07
0.08
4.3
2.7
ug/l
175.1
82.7
1.25
33
347
(40761511) CBC panel - Blood by Automated count
93
943
0.89
0.08
26.6
11.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
58
1.04
0.08
1.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
60
0.83
0.08
3.4
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
64
653
0.95
0.05
5.1
3.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
29
278
1.06
0.05
2.4
2.9
ng/l
1565.8
1554.3
0.00
24
235
(3007164) IgA [Mass/volume] in Serum or Plasma
19
180
1.07
0.04
1.8
1.2
g/l
2.1
2.4
0.27
12
98
(3012516) Albumin [Mass/volume] in Urine
31
301
1.04
0.03
2.9
3.0
mg/l
42.1
22.4
0.51
20
176
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
85
847
1.02
0.00
22.5
10.9
ml/min/173m2
73.9
76.1
0.36
76
664
(3041096) Erythrocytes [Presence] in Urine by Automated
26
257
1.02
0.00
4.8
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
32
317
1.01
0.00
3.2
3.6
mg/mmol
6.9
4.8
0.30
22
192
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
53
0.94
0.00
1.6
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
57
0.87
0.00
1.6
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
0.9
—
0
5
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
9.0
—
0
7
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
85.0
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
2.0
—
8.2
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
81
0.99
0.00
1.8
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
3.4
3.3
pmol/l
5.4
4.5
—
5
43
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
4.5
—
0
8
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
6.0
—
0
5
(3006270) Folate [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
311.4
—
0
9
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2176.0
—
0
5
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44813793)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
2.8
—
0
5
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
2.0
—
0
7
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
9.9
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
155.2
—
0
5
(3000034) Microalbumin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
4.7
—
9.1
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_VAGINA_EXALLC – Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).